Medicure Inc. (OTCMKTS:MCUJF) Short Interest Down 50.5% in April

Medicure Inc. (OTCMKTS:MCUJF) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 5,780 shares, a decrease of 50.5% from the April 15th total of 11,680 shares. Based on an average trading volume of 182 shares, the short-interest ratio is presently 31.8 days. Currently, 0.1% of the company’s stock are sold short.

Medicure Stock Performance

MCUJF opened at $0.80 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.02 and a quick ratio of 0.77. Medicure has a fifty-two week low of $0.68 and a fifty-two week high of $0.97. The firm has a market capitalization of $8.39 million, a PE ratio of -1.64 and a beta of 0.97. The company’s 50-day moving average is $0.83 and its 200 day moving average is $0.84.

Medicure (OTCMKTS:MCUJF) last posted its earnings results on Thursday, April 23rd. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.25). Medicure had a negative return on equity of 41.55% and a negative net margin of 24.61%.The business had revenue of $6.13 million during the quarter, compared to analyst estimates of $3.62 million.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.